&lt;i&gt;FGFR3-TACC3&lt;/i&gt; fusion as a potential primary resistance mechanism to EGFR-TKI in lung adenocarcinoma harboring co-driven mutations: a case report. The gene discussed is TACC3; the disease is lung adenocarcinoma.